NTLA_logo

Intellia Therapeutics, Inc

$7.58-$0.09  (1.17%)
EPS
-5.23
Market cap
$785.16M
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently asked questions

What sector does Intellia Therapeutics, Inc (NTLA) operate in?

Intellia Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Intellia Therapeutics, Inc (NTLA) current stock price?

As of the latest data, Intellia Therapeutics, Inc stock price is $7.58, with a previous close of $7.67. Intellia Therapeutics, Inc lost -$0.09 in the last trading session, representing a -1.17% loss.

What is Intellia Therapeutics, Inc (NTLA) current market capitalization?

Intellia Therapeutics, Inc market cap is approximately 785.16 million.

What is Intellia Therapeutics, Inc (NTLA) Earnings Per Share (EPS)?

The trailing EPS is -$5.23, and the forward EPS is -$4.33.

What is Intellia Therapeutics, Inc (NTLA) EBITDA?

Intellia Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -133.88 million.

Does Intellia Therapeutics, Inc (NTLA) pay dividends?

No. Intellia Therapeutics, Inc does not pay a dividend.

How did Intellia Therapeutics, Inc (NTLA) perform in its most recent earnings report?

In the last report (March 31, 2025), Intellia Therapeutics, Inc posted an EPS surprise of 3.52% and a revenue surprise of -75.29%.